Securities code: 688202 securities abbreviation: Shanghai Medicilon Inc(688202) Announcement No.: 2022-006 Shanghai Medicilon Inc(688202)
Announcement on the company’s failure to take regulatory measures or penalties by the securities regulatory authorities and stock exchanges in the past five years
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shanghai Medicilon Inc(688202) (hereinafter referred to as “the company”) has strictly complied with the company law of the people’s Republic of China, the securities law of the people’s Republic of China and the relevant regulations and requirements of the China Securities Regulatory Commission, Shanghai Stock Exchange and other regulatory authorities since its listing, continuously improved the corporate governance mechanism, established and improved the internal management and control system, and improved the level of corporate governance, Promote the continuous and standardized development of the company. According to the requirements of relevant laws and regulations, the company has conducted a self-examination on whether it has been punished or taken regulatory measures by the securities regulatory authorities and stock exchanges in the past five years. The results of the self-examination are as follows: I. The company has been punished by the securities regulatory authorities and stock exchanges in the past five years
In the last five years, the company has not been punished by the securities regulatory authorities and Shanghai Stock Exchange. 2、 The company has been subject to regulatory measures taken by the securities regulatory department and the stock exchange in the past five years. In the past five years, the company has not been subject to regulatory measures taken by the securities regulatory department and the Shanghai Stock Exchange.
It is hereby announced.
Shanghai Medicilon Inc(688202) board of directors February 11, 2022
